SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-007632
Filing Date
2022-02-24
Accepted
2022-02-24 16:54:50
Documents
2
Period of Report
2022-02-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5278
2 EX-24 DOCUMENT attachment1.htm EX-24 4569
  Complete submission text file 0000899243-22-007632.txt   11197
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Issuer) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address IKENA ONCOLOGY, INC. 645 SUMMER STREET, SUITE 101 BOSTON MA 02210
Business Address
Oliveira Francisco (Reporting) CIK: 0001909287 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40287 | Film No.: 22672015